These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18181327)

  • 41. Hilar cholangiocarcinoma: current management.
    Ito F; Cho CS; Rikkers LF; Weber SM
    Ann Surg; 2009 Aug; 250(2):210-8. PubMed ID: 19638920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical value of CT-guided high frequency-induced thermotherapy as a treatment for intrahepatic cholangiocarcinoma].
    Fan WJ; Zhang L; Gu YK; Wang LG; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(25):1759-62. PubMed ID: 19035087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
    Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of hilar biliary strictures by using a newly developed forward-viewing therapeutic echoendoscope: preliminary results of an ongoing experience.
    Larghi A; Lecca PG; Ardito F; Rossi ED; Fadda G; Nuzzo G; Costamagna G
    Gastrointest Endosc; 2009 Feb; 69(2):356-60. PubMed ID: 19185697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of portal vein embolization in hepatobiliary malignancy.
    Sirichindakul B; Nonthasoot B; Taesombat W; Supaphol J; Nivatvongs S; Janchai A; Tantivatana J
    Hepatogastroenterology; 2007 Dec; 54(80):2297-300. PubMed ID: 18265651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful liver transplantation for hilar cholangiocarcinoma.
    Heimbach JK
    Curr Opin Gastroenterol; 2008 May; 24(3):384-8. PubMed ID: 18408469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of combined hepatocellular and cholangiocarcinoma.
    Kassahun WT; Hauss J
    Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification and establishment of CT criteria in preoperative assessment of portal venous invasion by hilar cholangiocarcinoma.
    Zhou Q; Guan Y; Mao L; Zhu Y; Chen J; Shi J; Tang M; Qiu Y; Zhu B; He J
    HPB (Oxford); 2018 Dec; 20(12):1163-1171. PubMed ID: 30030081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma.
    Takayasu K; Muramatsu Y; Shima Y; Moriyama N; Yamada T; Makuuchi M
    Radiology; 1986 Aug; 160(2):389-93. PubMed ID: 3014598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MR signal intensity changes in hepatic parenchyma with ductal dilation caused by intrahepatic cholangiocarcinoma.
    Yoshimitsu K; Honda H; Kaneko K; Kuroiwa T; Fukuya T; Irie H; Kajiyama K; Takenaka K; Masuda K
    J Magn Reson Imaging; 1997; 7(1):136-41. PubMed ID: 9039604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biliary inflammatory pseudotumor: imaging features in seven patients.
    Tublin ME; Moser AJ; Marsh JW; Gamblin TC
    AJR Am J Roentgenol; 2007 Jan; 188(1):W44-8. PubMed ID: 17179326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correct diagnosis of vascular encasement and longitudinal extension of hilar cholangiocarcinoma by four-channel multidetector-row computed tomography.
    Okumoto T; Sato A; Yamada T; Takase K; Matsuhashi T; Tsuda M; Seiji K; Ishibashi T; Higano S; Katayose Y; Unno M; Takahashi S
    Tohoku J Exp Med; 2009 Jan; 217(1):1-8. PubMed ID: 19155601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Dual phase spiral CT in hepatic hilar masses].
    Stietzel C; Kösling S
    Rofo; 1998 Jan; 168(1):10-4. PubMed ID: 9501928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arterially enhancing liver lesions: significance of sustained enhancement on hepatic venous and delayed phase with magnetic resonance imaging.
    Brancatelli G; Federle MP; Baron RL; Lagalla R; Midiri M; Vilgrain V
    J Comput Assist Tomogr; 2007; 31(1):116-24. PubMed ID: 17259843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple stenting in hilar bile duct carcinoma: three-branched partial stent-in-stent deployment with the JOSTENT SelfX.
    Kawamoto H; Ishida E; Ogawa T; Okamoto Y; Okazaki H; Kato J; Okada H; Shiratori Y
    Endoscopy; 2004 Sep; 36(9):829-30. PubMed ID: 15326581
    [No Abstract]   [Full Text] [Related]  

  • 58. [The value of three-dimensional 64-multi-slices helical computer tomography on the diagnosis of diseases of digestive system].
    Fang CH; Xiang N; Fan YF; Yang J; Quan XY; Liang W; Tang HL
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):909-12. PubMed ID: 17953840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis.
    Ruys AT; van Beem BE; Engelbrecht MR; Bipat S; Stoker J; Van Gulik TM
    Br J Radiol; 2012 Sep; 85(1017):1255-62. PubMed ID: 22919007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for hilar cholangiocarcinoma: a case-control study in China.
    Cai WK; Sima H; Chen BD; Yang GS
    World J Gastroenterol; 2011 Jan; 17(2):249-53. PubMed ID: 21246000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.